Biofrontera AG
BFFTF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $9,012 | $7,839 | $7,901 | $10,596 |
| % Growth | 15% | -0.8% | -25.4% | – |
| Cost of Goods Sold | $4,801 | $4,342 | $3,946 | $5,663 |
| Gross Profit | $4,211 | $3,497 | $3,955 | $4,933 |
| % Margin | 46.7% | 44.6% | 50.1% | 46.6% |
| R&D Expenses | $669 | $621 | $17 | $33 |
| G&A Expenses | $0 | $0 | $0 | $9,060 |
| SG&A Expenses | $8,425 | $7,947 | $9,250 | $8,765 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$295 |
| Other Operating Expenses | $77 | $0 | $166 | $66 |
| Operating Expenses | $9,095 | $8,568 | $9,433 | $8,798 |
| Operating Income | -$4,960 | -$5,071 | -$5,467 | -$3,865 |
| % Margin | -55% | -64.7% | -69.2% | -36.5% |
| Other Income/Exp. Net | -$706 | $4,834 | -$4,969 | $7,385 |
| Pre-Tax Income | -$5,666 | -$237 | -$10,436 | $3,520 |
| Tax Expense | $3 | $20 | $1 | -$6 |
| Net Income | -$5,669 | -$257 | -$10,437 | $3,526 |
| % Margin | -62.9% | -3.3% | -132.1% | 33.3% |
| EPS | -0.98 | -0.051 | -2.88 | 1.65 |
| % Growth | -1,840.6% | 98.2% | -274.5% | – |
| EPS Diluted | -0.98 | -0.051 | -2.88 | 1.65 |
| Weighted Avg Shares Out | 5,774 | 5,091 | 3,624 | 2,140 |
| Weighted Avg Shares Out Dil | 5,774 | 5,091 | 3,624 | 2,140 |
| Supplemental Information | – | – | – | – |
| Interest Income | $17 | $24 | $14 | $21 |
| Interest Expense | $9 | $620 | $1,421 | $233 |
| Depreciation & Amortization | $312 | $309 | $307 | $295 |
| EBITDA | -$4,960 | $692 | -$8,708 | $4,048 |
| % Margin | -55% | 8.8% | -110.2% | 38.2% |